1. Oriel JD. The history of Chlamydial infections. “Orfilla J, Byrne GI, Chernesky MA, Grayston JT, Jones RB, Ridgway GL, Saikku P, Schachter J, Stamm WE, Stephens RS (eds): Proceeding of
the Eight International symposium on human chlamydial infections” p.3. France. 1994.
2. Kihlstrom E. Chlamydial molecular biology. “Mardh PA, Saikku P (eds):” Chlamydial infections of genital and respiratory tracts and allied conditions”. p. 3. France. 1994.
3. Schachter J. Chlamydial infections.West J Med. 1990; 153(5): 523-534.
4. Önel M, Ağaçfidan A. Chlamydia infeksiyonları: Dünü, bugünü ve geleceği. Aktepe OC, Ağaçfidan A.(eds). III Ulusal Chlamydia İnfeksiyonları simpozyumu kitabı. Birmat Matbaacılık. 2006.
5. Durmuş MA, Ağaçfidan A. Chlamydia cinsi. In: Ağaçfidan A (ed) Aydın D, Derbentli Ş, Gürler N, Uzun M (Bölüm eds). Tıbbi Mikrobiyoloji. Nobel Tıp Kitabevleri Tic. Ltd Şti., 2023.
6. Ertem E. Chlamydia trachomatis. In: Wilke Topçu A, Söyletir G, Doğanay M. eds. Enfeksiyon Hastalıkları ve Mikrobiyoloji 4. Baskı. Nobel Tıp Kitabevleri Tic. Ltd. Şti., 2017.
7. Stamm WE, Batteiger BE. Chlamydia trachomatis (Trachoma, perinatal infections, lymphogranuloma venereum and other genital infections) In Mandell, Douglas and Bennett’s Principles
and Practice of Infectious Disease. (Eds: Mandell GL, Bennett JE, Dolin R) 7th ed. Vol. 2 Philadelphia, Churchill Livingstone, 2010; 2443-2461.
8. Riedel S, Hobden JA, Miller S, Morse SA, Mietzner TA, Detrick B, Mitchell TG, Sakanari JA, Hotez P, Mejia R. Jawetz, Melnick ve Adelberg Chlamydia türleri s.367-377. Tıbbi Mikrobiyoloji. çev. Yenen
OŞ. İstanbul: Nobel Tıp Kitabevleri. 2024.
9. Phillips JA. Chlamydia Infections. Workplace Health Safety 2019; 67(7): 375-376.
10. Ağaçfidan A. Chlamydia pneumoniae. In: Wilke Topçu A, Söyletir G, Doğanay M. eds. Enfeksiyon Hastalıkları ve Mikrobiyoloji 4. Baskı. Nobel Tıp Kitabevleri Tic. Ltd. Şti., 2017.
11. Roulis E, Polkinghorne A, Timms P. Chlamydia pneumoniae: modern insights into an ancient pathogen. Trends Microbiol. 2013; 21(3): 120-128.
12. Laurila AL, Anttila T, Läärä E et al. Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer. 1997; 74(1): 31-34.
13. Chaturvedi AK, Gaydos CA, Agreda P et al. Chlamydia pneumoniae infection and risk for lung cancer. Cancer Epidemiol Biomarkers Prev. 2010; 19(6):1498-1505.
14. Knittler MR, Sachse K. Chlamydia psittaci: update on an underestimated zoonotic agent. Pathog Dis. 2015; 73(1): 1-15.
15. Ağaçfidan A. Chlamydia psittaci. In: Wilke Topçu A, Söyletir G, Doğanay M. eds. Enfeksiyon Hastalıkları ve Mikrobiyoloji 4. Baskı. Nobel Tıp Kitabevleri Tic. Ltd. Şti., 2017.
16. Tolba HMN, Abou Elez RMM, Elsohaby I. Risk factors associated with Chlamydia psittaci infections in psittacine birds and bird handlers. J Appl Microbiol. 2019; 126: 402-410.
17. Weiss E. Rickettsiae and Chlamydia taxonomy. “Balaus A, Hauster JW, Herman KL, Isenberg HD (eds). Manual of Clinical Microbiology”. 5th edition kitabında. s. 1033-1035 Washington
1991.
18. Schaffner W. TWAR “Mandell GL, Douglas RG, Bennett JE (eds) Principales and Practice of Infectious Disease. p.1443-1444, Churcill Livingstone, New York 1990.
19. Fukushi H, Hirai K. Chlamydia pecorum–the fourth species of genus Chlamydia. Microbiol Immunol. 1993;37(7):516-22.
20. Mahony JB, Coombes BK, Chernesky MA. Chlamydia and Chlamydophila. “Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds). Manual of Clinical Microbiology “ 8th Edition.
p.991 ASM Pressing. Washington 2003.
21. Zaręba-Marchewka K, Szymańska-Czerwińska M, Livingstone M, Longbottom D, Niemczuk K. Whole Genome Sequencing and Comparative Genome Analyses of Chlamydia abortus Strains
of Avian Origin Suggests That Chlamydia abortus Species Should Be Expanded to Include Avian and Mammalian Subgroups. Pathogens. 2021; 10(11): 1405.
22. Vorimore F, Hölzer M, Liebler-Tenorio EM, et al. Evidence for the existence of a new genus Chlamydiifrater gen. nov. inside the family Chlamydiaceae with two new species isolated from
flamingo (Phoenicopterus roseus): Chlamydiifrater phoenicopteri sp. nov. and Chlamydiifrater volucris sp. nov. Syst Appl Microbiol. 2021; 44(4): 126200.
23. Luu LDW, Kasimov V, Phillips S et al.Genome organization and genomics in Chlamydia: whole genome sequencing increases understanding of chlamydial virulence, evolution and phylogeny.
Front Cell Infect Microbiol. 2023; 13:1178736.
24. Elwell C, Mirrashidi K, Engel J. Chlamydia cell biology and pathogenesis. Nat Rev Microbiol. 2016; 14(6): 385-400.
25. Ertem E. Klamidyaların genel özellikleri. In: Wilke Topçu A, Söyletir G, Doğanay M. eds. Enfeksiyon Hastalıkları ve Mikrobiyoloji 4. Baskı. Nobel Tıp Kitabevleri Tic. Ltd. Şti., 2017.
26. Murray SM, McKay PF. Chlamydia trachomatis: Cell biology, immunology and vaccination. Vaccine. 2021; 39(22): 2965-2975.
27. Gitsels A, Sanders N, Vanrompay D. Chlamydial Infection From Outside to Inside. Front Microbiol. 2019; 10: 2329.
28. Nunes A, Gomes JP. Evolution, phylogeny, and molecular epidemiology of Chlamydia. Infect Genet Evol. 2014; 23: 49-64.
29. Clarke IN. Evolution of Chlamydia trachomatis. Ann N Y Acad Sci. 2011; 1230: E11-E18.
30. Stamm WE, Batterger BE. Introduction Chlamydia and Chlamydophila. In Mandell GI, Benett JE, Dolin R (ed). Principles and Practice of Infectious Disease. USA, Churchill Livingstone
2010; 2439-2442.
31. Christiansen G, Burkelund S. Chlamydia structure. A molecular approach to understand to structure of Chlamydia. Chlamydial Infections. Proceedings of the 10th International Symposium
on human Chlamydial Infections. Schachter J et al. p. 537-546. June 16-21, 2002, Antalya, Turkey.
32. Serter D. Virüs, Riketsia ve Klamidya Hastalıkları. Nobel Tıp Kitabevi. 1997.
33. Agacfidan A, Moncada J, Aydin D et al. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in Turkey among men With urethritis. Sex Transm Dis. 2001; 28 (11): 630-2.
34. Agacfidan A, Chow JM, Pashazade H, Özarmagan G, Badur S. Screening of sex workers in Turkey for Chlamydia trachomatis. Sex Transm Dis. 1997; 24(10): 573-5.
35. Dereli D, Ertem E, Serter D, Yüce K. Evaluation of direct fluorescent antibody test for detection of Chlamydia trachomatis in endocervical specimens. APMIS. 1991; 99: 961-4.
36. Schachter J. Epidemiology of Chlamydial infections: Identifying high risk populations, STD update. 1988; 1: 27.
37. Gencay M, Dereli D, Ertem E et al. Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in İzmir, Turkey. Eur J Epidemiol. 1998; 14:
505-509.
38. Cheong HC, Lee CYQ, Cheok YY, Tan GMY, Looi CY, Wong WF. Chlamydiaceae: Diseases in Primary Hosts and Zoonosis. Microorganisms. 2019; 7(5): 146.
39. Shi Y, Chen J, Shi X, et al. A case report of Chlamydia psittaci caused severe pneumoniae and meningitis diagnosed by metagenome next- generation sequencing and clinical analysis: a case
report and literatüre review. BMC Infectious Diseases. 2021; 21:621
40. Mardh P-A, Domeika M. Pneumoniae and allied conditions caused by Chlamydia psittaci and Chlamydia pneumoniae. Anğ Ö, Badur S, Ağaçfidan A. (eds). Chlamydia infeksiyonları ve
tanıda yenilikler kitabı. s. 37-44. Türk Mikrobiyol Cem Yayın No:20 İstanbul,1994.
41. Edmond RTD, Welsby PD, Rowland HAK. İnfeksiyon Hastalıkları Renkli Atlas. çev. Uzun C, Yumuk Z, Anğ Ö. İstanbul: Nobel Tıp Kitabevleri. 2011.
42. Dong YZ, Sasagawa T, Fang SY et al. Human papilloma virüs, Chlamydia trachomatis and other risk factors associated with cervical cancer in China. Int J Clin Oncol. 1998; 3: 81-87.
43. Kalimo K, Terho P, Honkonen E et al. Chlamydia trachomatis and herpes simplex virus IgA antibodies in cervical secretions of patients with cervical atypia. Br J Obstet Gynaecol. 1981; 88(11):
1130-1134.
44. da Silva Barros NK, Costa MC, Alves RR et al. Association of HPV infection and Chlamydia trachomatis seropositivity in cases of cervical neoplasia in Midwest Brazil. J Med Virol. 2012;
84(7): 1143-1150.
45. Önel M. Servikal kanser ile Chlamydia trachomatis arasındaki ilişkinin araştırılması. Doktora Tezi. İstanbul Üniversitesi, Sağlık Bilimleri Enstitüsü, 2003.
46. Hare MJ, Taylor-Robinson D, Cooper P. Evidence for an association between Chlamydia trachomatis and cervical intraepithelial neoplasia. Br J Obstet Gynaecol. 1982; 89(6): 489-492.
47. Bendjelloul I, Lourtet-Hascoët J, Galinier JL et al. Chlamydia psittaci endocarditis: A case report and literature review. Infect Dis Now. 2023; 53(5): 104687.
48. Beka H, Bozkaya E. Chlamydia trachomatis’in direkt tanısında “gold standart” değişiyor mu? III. Ulusal Chlamydia infeksiyonları simpozyumu kitabı. In O.C. Aktepe, A. Ağaçfidan (eds).
93-97 (2006).
49. Ağaçfidan A. Chlamydia trachomatis’in laboratuvar tanısı. Cinsel Temasla Bulaşan Hastalıklar (CTBH) Kitabı In. A. Ağaçfidan, Ö. Anğ (eds). S.125-133. 1999, İstanbul.
50. Dukers-Muijrers NHTM, Evers YJ, Hoebe CJPA, et al. Controversies and evidence on Chlamydia testing and treatment in asymptomatic women and men who have sex with men: a narrative
review. BMC Infect Dis. 2022; 22(1): 255.
51. Shetty S, Kouskouti C, Schoen U et al. Diagnosis of Chlamydia trachomatis genital infections in the era of genomic medicine. Braz J Microbiol. 2021; 52(3):1327-1339.
52. Schachter J, Dawson CR. Laboratory diagnosis of human chlamydial infections kitabında. 1978. p.181-219
53. Hammerschlag MR, Sharma R. Azithromycin in the treatment of rectogenital Chlamydia trachomatis infections: end of an era? Expert Rev Anti Infect Ther. 2021;19(4): 487-493.
54. Potroz MG, Cho NJ. Natural products for the treatment of trachoma and Chlamydia trachomatis. Molecules. 2015; 20(3): 4180-4203.
55. Erdoğru T, Agacfidan A, Onel M et al. The treatment of non-gonococcal urethritis with single dose oral azithromycin. J Med Res. 1998; 23: 386-93.
56. Liu J, Gao Y. Tigecycline in the treatment of severe pneumonia caused by Chlamydia psittaci: A case report and literature review. Front Med. 2022; 9: 1040441.
57. Tuddenham S, Hamill MM, Ghanem KG. Diagnosis and Treatment of Sexually Transmitted Infections: A Review. JAMA. 2022; 327(2): 161-172.
58. Hou C, Jin Y, Wu H et al. Alternative strategies for Chlamydia treatment: Promising non-antibiotic approaches. Front Microbiol. 2022; 13: 987662.
59. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. Public health assessment of potential biological terrorism agents. Emerg Infect Dis. 2002; 8(2): 225-30.